Ask the Experts: Gastroenterology
Medscape's Ask the Experts allows you to ask members of a panel of leading experts for advice or information. You also have the opportunity to share your own views and insights by clicking the "Discuss this" link at the top of each response.
Ask the Experts
- How Should I Manage Patients With Sickle Cell Anemia and Hepatitis C?
- How Should I Manage the Pregnant HBeAg-Positive Woman?
- How Should We Manage Drug Interactions Between Clopidogrel and Proton-Pump Inhibitors?
- Does HBsAg Clear After Treatment of Hepatitis B Infection?
- Endoscopic Eradication Therapy for Barrett's Esophagus
- How Should Inflammatory Bowel Disease Be Managed During Pregnancy?
- What Is the Role of FibroScan in Diagnosing Liver Fibrosis?
- The Inactive Carrier State in Chronic Hepatitis B Infection
- Management of Non-Alcoholic Fatty Liver Disease
- How Should Crohn's Disease Be Managed in Pregnancy
- Triple Rule-out CTA in the Emergency Department
- Is Gardasil® Recommended for Young Women Already Exposed to HPV?
- What Are the Pros and Cons of Using Bundles to Prevent Infection in the ICU?
- Do All HCV-Infected Patients Need a Liver Biopsy Before Treatment?
- What Antibiotic Covers Methicillin-sensitive Staphylococcus aureus (MSSA) Infection?
- When Is Skin Testing for Penicillin Allergy Indicated?
- Is It Safe To Order Drugs From Overseas Pharmacies?
- Ask the Experts: Do Sex-Related Differences Affect Clinical Course and Outcome in Crohn's Disease?
- Approach to the Treatment of HCV Nonresponders
- Do cccDNA Levels Have a Role in Predicting Response to Treatment in Hepatitis B?
Disclaimer
The information in this web site reflects the views of the authors only and not Medscape. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers should verify all information and data before treating patients or utilizing any therapies noted in this program.
Expert Panel
-
John Baillie, MB, ChB, FRCP, FASGE, Wake Forest University Medical Center and Health Sciences, Winston-Salem, North Carolina; Director, Hepatobiliary and Pancreatic Disorders Service, Baptist Medical Center, Winston-Salem, North Carolina
-
William F. Balistreri, MD, Dorothy M. M. Kersten Professor of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Medical Director, Liver Transplantation Program, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
-
David Bernstein, MD, Chief, Digestive Disease Institute, North Shore University Hospital-Long Island Jewish Medical Center, Manhasset, New York; Associate Professor of Medicine, New York University School of Medicine, New York, NY
-
Sunanda V. Kane, MD, MSPH, FACG, Associate Professor of Medicine, Mayo Clinic, Rochester, Minnesota
-
Bret A. Lashner, MD, Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland, Ohio
-
Paul Martin, MD, Professor of Medicine and Chief, Division of Hepatology, Center for Liver Disease, University of Miami School of Medicine, Miami, Florida
-
Brant K. Oelschlager, MD, Associate Professor, Department of Surgery, University of Washington, Seattle; Director, The Swallowing Center, University of Washington Medical Center, Seattle, Washington
-
Yehuda Ringel, MD, Assistant Professor of Medicine, University of North Carolina at Chapel Hill
-
Prateek Sharma, MD, Professor of Medicine, University of Kansas School of Medicine, Kansas City, Missouri
Rowen K. Zetterman, MD, FACG,Professor of Internal Medicine, University of Nebraska, Omaha; Clinical Professor of Medicine, Creighton University, Omaha, Nebraska